ETF · iShares
0JGB iShares Biotechnology ETF
ISIN US4642875565London Stock Exchange: 0JGBBlackRock, Inc.
- Technology
- ETF
- Distributing
Latest close
LSE$204.76
on
- Ongoing charge
- 0.44% a year
- Fund size
- £6.0bn
Source: TradingView, as of , at least 15 min delayed
At a glance
As of 05/10/2026, 0JGB (iShares Biotechnology ETF, ISIN US4642875565) closed at $204.76 on the London Stock Exchange. Its ongoing charge is 0.44% a year (about £44 on £10,000). Over the five years to 05/10/2026 its total return was +34.7%, or +5.3% after UK CPIH inflation.
Past returns
- 1 year to 05/10/2026
- +39.7%
- +35.4% after inflation (UK CPIH)
- 3 years to 05/10/2026
- +58.1%
- +42.7% after inflation (UK CPIH)
- 5 years to 05/10/2026
- +34.7%
- +5.3% after inflation (UK CPIH)
£1,000 put in five years ago would have been worth about £1,347 on 05/10/2026 — about £1,053 in today’s spending power, once price rises are taken out. Past performance is not a guide to future returns.
Returns: TradingView (delayed data). Inflation: ONS CPIH, latest month published.
How we work it out:ReturnsReturns after inflationTotal returnReal returnCPIH
Calendar-year and 12-month returns
Calendar-year returns of iShares Biotechnology ETF in pounds (price only, income paid out not included): 2021 −0.3%, 2022 −6.7%, 2023 +0.1%, 2024 −0.4%, 2025 +20.4%; 2026 to 02/10/2026 +20.9%. Returns of iShares Biotechnology ETF in pounds (price only, income paid out not included) over the 12 months to 30/09/2026: +52.2%; to 30/09/2025: −4.0%; to 30/09/2024: +8.8%; to 30/09/2023: −4.9%; to 30/09/2022: −15.6%.
| Year | Return | After inflation | Return shown as a bar |
|---|---|---|---|
| to | +20.9% | +17.5% | |
| +20.4% | +16.2% | ||
| −0.4% | −3.8% | ||
| +0.1% | −3.9% | ||
| −6.7% | −14.6% | ||
| −0.3% | −4.9% |
| 12 months to | Return | After inflation |
|---|---|---|
| from | +52.2% | Not available |
| from | −4.0% | −7.7% |
| from | +8.8% | +6.1% |
| from | −4.9% | −10.6% |
| from | −15.6% | −22.5% |
Source: Fundology, from recorded closes and the data vendor’s weekly price history, as of , inflation: ONS CPIH
How we work it out:Calendar-year returnsWhat a calendar-year return isAccumulating and distributing
Risk: volatility and largest fall
Volatility (annualised)
20.9%over 5 years
| 1 year | 20.0% |
|---|---|
| 3 years | 19.7% |
| 5 years | 20.9% |
Annualised from weekly returns. Higher means bumpier.
- Largest fall since October 2021
- −26.4%
- From to
- Lowest 12-month return
- −24.5%
- 12 months to
- Highest 12-month return
- +51.9%
- 12 months to
- Below its highest weekly close since October 2021
- 1.8%
- High of , latest
In words: Volatility of iShares Biotechnology ETF in pounds, annualised from weekly returns to 02/10/2026: 20.0% over 1 year, 19.7% over 3 years, 20.9% over 5 years. Largest fall in the price of iShares Biotechnology ETF since October 2021, in pounds: −26.4% from 26/11/2021 to 17/06/2022. The lowest 12-month return of iShares Biotechnology ETF in pounds (price only, income paid out not included) since December 2020 was −24.5% (12 months to 17/06/2022); the highest was +51.9% (12 months to 03/07/2026). On 02/10/2026 the price of iShares Biotechnology ETF was 1.8% below its highest weekly close since October 2021 (03/09/2026), in pounds.
Source: Fundology, from recorded closes and the data vendor’s weekly price history, as of , price only — income paid out is not included
How we work it out:Risk figuresFallsVolatilityLargest fall
Charges compared with similar funds
- Ongoing charge
- 0.44%
- a year
- On £10,000
- £44
- a year, roughly
- Over five years
- £218
- of £10,000, before growth
- 45 charge less
- 1 the same
- 73 charge more
Ongoing charge of iShares Biotechnology ETF 0.44% a year, as of 03/10/2026: 73 of the 119 other technology funds charge more, 1 the same and 45 less (share classes counted once).
Source: Fund ongoing charges via TradingView, as of
A lower charge is not a promise of a higher return: what the fund holds matters more. Charges are the fund’s own published ongoing charges figure.
Read more:Ongoing charge (OCF)OCF and TERFee dragHow charges add up
In plain English
iShares Biotechnology ETF is an exchange-traded fund (ETF) from iShares, launched in 2001.
It tracks the NYSE Biotechnology (TR).
You buy and sell it through a share-dealing account or platform during stock-market hours, like a share.
Its ongoing charge is 0.44% a year — about £44 a year on every £10,000 invested, taken from the fund's value rather than billed to you.
Income from its investments is paid out to holders as cash, usually a few times a year.
Technology: Software, chips, AI and other tech companies. One sector only, so prices can move more than a broad fund.
Key facts
- Ticker
- 0JGB
- ISIN
- US4642875565
- Provider
- iShares
- Tracks
- NYSE Biotechnology (TR)
- Structure
- ETF
- An exchange-traded fund: bought and sold on the stock exchange through the day, like a share.
- Income
- Distributing, paid quarterly
- Income is paid out to holders as cash, usually a few times a year.
- Ongoing charge
- 0.44% a year · about £44 on £10,000
- Fund size
- £6.0bn
- Launched
- Domicile
- United States
- Currency hedged
- No
- Price currency
- USD
- Category
- Technology
Price chart
Since 31/07/2026, the closing price went from $185.26 on 31/07/2026 to $204.76 on 05/10/2026 (+10.5%). The lowest close shown was $185.26 on 31/07/2026 and the highest $214.54 on 21/08/2026.
Chart: closing prices we have recorded since 31/07/2026. Price only — income paid out is not included, so the line can end below the total return above.
Source: TradingView, as of , at least 15 min delayed
Five years of prices, and after inflation
11 weekly closes, from 31/07/2026 to 05/10/2026. The same history in October 2026 pounds, adjusted with ONS CPIH inflation.
Create a free account to see the 5-year price chart and the after-inflation chart
Sign-up takes an email address. There is no card to enter and nothing to pay.
How we work it out:Prices and returnsNAV and price
Risk and return in depth
Sharpe, Sortino and Calmar ratios
Sharpe, Sortino and Calmar ratios over 1, 3 and 5 years, from weekly returns in pounds.
With a free accountRolling returns
The full range of 243 rolling 12-month returns since December 2020, and of 144 rolling three-year returns, in pounds, with how often they were above zero.
With a free accountLargest falls and recoveries
The 3 largest falls since October 2021, in pounds, with how many weeks each took to reach its low and to recover.
With a free account
Create a free account to see the risk ratios, every rolling return and each large fall and its recovery
Sign-up takes an email address. There is no card to enter and nothing to pay.
Moves compared with a similar fund
Correlation and beta of weekly returns in pounds against iShares Core MSCI World UCITS ETF, over the three years to 02/10/2026 (151 weeks).
Pro
Pro — currently by invitation
Pro includes moves against a comparable fund
Pro is open by invitation while it is being built. There is nothing to buy. To ask about access, email [email protected].
Questions people ask
What is the ongoing charge of 0JGB?
The ongoing charge of 0JGB is 0.44% a year — about £44 a year on every £10,000 invested, taken from the fund’s value rather than billed to you. Platform and dealing fees are charged separately. Ongoing charge of iShares Biotechnology ETF 0.44% a year, as of 03/10/2026: 73 of the 119 other technology funds charge more, 1 the same and 45 less (share classes counted once).
What does 0JGB track?
0JGB tracks the NYSE Biotechnology (TR).
Is 0JGB accumulating or distributing?
0JGB is distributing: income is paid out to holders as cash, usually a few times a year. It pays out quarterly.
What is the ISIN of 0JGB?
The ISIN of 0JGB is US4642875565. An ISIN identifies one exact share class of a fund; 0JGB is its ticker on the London Stock Exchange.
What were 0JGB’s returns in each of the last five years?
Calendar-year returns of 0JGB in pounds (price only, income paid out not included): 2021 −0.3%, 2022 −6.7%, 2023 +0.1%, 2024 −0.4%, 2025 +20.4%; 2026 to 02/10/2026 +20.9%. Past performance is not a guide to future returns.
How has 0JGB done after inflation?
Over the five years to 05/10/2026 0JGB’s total return was +34.7%, or +5.3% after UK CPIH inflation. Past performance is not a guide to future returns.
Similar funds
- IITUiShares S&P 500 Information Technology Sector UCITS ETF0.15% a year · £12bn
- SMGBVanEck Semiconductor UCITS ETF Accum A USD0.35% a year · £5.6bn
- XAIXXtrackers Artificial Intelligence & Big Data UCITS ETF0.35% a year · £5.4bn
- SEMIiShares MSCI Global Semiconductors UCITS ETF AccumUSD0.35% a year · £3.9bn
- XXTWXtrackers MSCI World Information Technology UCITS ETF0.25% a year · £3.8bn
- RBTXiShares Automation & Robotics UCITS ETF0.40% a year · £3.2bn
- ISPYL&G Cyber Security UCITS ETF0.73% a year · £2.4bn
- 0MVVAmundi MSCI World Information Technology UCITS ETF EUR ACC0.30% a year · £2.0bn
Sources and dates
- Prices
- London Stock Exchange closes via TradingView, at least 15 minutes delayed, latest
- Returns
- TradingView reported returns (net asset value with income reinvested where available)
- Calendar years, risk
- Fundology, from recorded closes (weekly history from the data vendor where our record is short)
- Inflation
- ONS CPIH, latest month used August 2026
- Charges
- The fund’s ongoing charges figure, via TradingView
- Identity
- FCA Financial Instruments Reference Data System (FIRDS) and the issuer
- Fund size
- TradingView, converted to pounds at the latest ECB reference rate
Methodology:Data sourcesReturnsCategoriesAll methods
A machine-readable copy of this page: Markdown.